Checkpoint Therapeutics, Inc. (CKPT)
CKPT Chart as of 2025-03-10
Stock Information
| CEO: | – |
| CFO: | – |
| Employees: | 23 |
| Address: | 95 Sawyer Road, Waltham, MA, United States |
| Country: | United States |
| Website: | https://checkpointtx.com |
| Listing Date: | – |
| Founded: | – |
| Founder: | – |
| Current Price: | 4.13 USD |
| Today Change: | 67.21% |
| Outstanding Shares: | 48,132,500 |
| Volume: | 619,388 |
| Avg Volume: | 1,325,079 |
| Expert Target Price: | 12.0000 (Institutions: 0) |
| EPS: | – |
| PER: | – |
| Dividend Date: | – |
| Last Split Date: | 2022-12-06 |
| Last Split Factor: | 1:10 |
Key Executives
| Name | Title | Pay | Year |
|---|---|---|---|
| Mr. James F. Oliviero III, C.F.A. | President, CEO & Director | 921.59k | — |
| Mr. William Garrett Gray CPA | CFO, Corporate Secretary & Treasurer | 409.12k | — |
Financials
Income Statement
| Metric | Amount |
|---|---|
| Total Revenue | 103,000 |
| Cost Of Revenue | – |
| Gross Profit | – |
| Operating Income | -52,148,000 |
| Net Income | -51,847,000 |
Balance Sheet
| Metric | Amount |
|---|---|
| Total Assets | 5,378,000 |
| Total Liabilities | – |
| Total Stockholder Equity | – |
Cash Flow
| Metric | Amount |
|---|---|
| Total Cash From Operating Activities | – |
| Capital Expenditures | – |
SEC Filings (Gemini Summaries)
| AccNo | Date | Summary |
|---|---|---|
| 0001104659-25-021976 | 2025-03-10 | Checkpoint Therapeutics (CKPT) entered a merger agreement on March 9, 2025, with Sun Pharmaceutical Industries. CKPT will merge with a Sun Pharma subsidiary, becoming a wholly-owned subsidiary. Stockholders receive $4.10 cash + a CVR (up to $0.70). Total deal value is up to $416M. |
| 0001104659-25-021973 | 2025-03-10 | Checkpoint Therapeutics (CKPT) filed an 8-K on 3/9/25 re: a merger agreement with Sun Pharmaceutical Industries. CKPT will merge with Sun Pharma’s subsidiary. Stockholders receive $4.10 cash + a contingent value right (CVR) for up to $0.70 based on milestones. |
| 0001415889-25-005849 | 2025-02-27 | Form 4 filing by Fortress Biotech, Inc. regarding Checkpoint Therapeutics, Inc. (CKPT) on 02/26/2025. Fortress Biotech is a 10% owner. Reports acquisition of 18,500 shares of common stock. |
| 0001172661-25-001299 | 2025-02-14 | This SEC filing excerpt defines CSS styles for text boxes and tables. It specifies borders, fonts, colors, alignment, and padding for various table elements. |
| 0001104659-25-011656 | 2025-02-11 | SEC Form 4 filing by James F Oliviero III, CEO, President & Director of Checkpoint Therapeutics (CKPT) on 02/07/2025. Reports disposition of 9,233 shares of common stock at $3.41. |
News Summary
– Bring Silent Videos to Life Sounds(Open-Source)
2025-02-28 07:05:23 | Github.com
FoleyCrafter: Bring Silent Videos to Life with Lifelike and Synchronized Sounds. AI拟音大师，给你的无声视频添加生动而且同步的音效 – open-mmlab/FoleyCrafter
Link
– 【Ubuntu日和】【第69回】GPT-SoVITSを使えば、機械が自分の声で喋ってくれるようになるぞ！
2025-02-14 21:14:00 | Impress.co.jp
「他者とのコミュニケーションに対して心理的支障を抱えている人」は、得てして自分の声や発声能力に対してもコンプレックスを持っているものである。思い通りの声色が出せない、どもってしまう、だんだん声が小さくなっていく、言葉の始めに「あっ」とか「えっと」とかつけてしまう、台本通りに読もうと思ってもつっかえるなどなど、程度の差こそあれその理由は千差万別だ。本来は適切なトレーニングを受ければある程度解消はするらしいが、あくまで「ある程度」となる。
Link
– Transformer-Squared：停止微调 LLMs – 果冻人工智能
2025-02-14 02:47:00 | Cnblogs.com
Transformer-Squared：停止微调 LLMs 自适应大语言模型背后的架构、Transformer-Squared 的数学与代码，以及奇异值分解 DALL-E 生成的图片 我们已经进入了这样一个时代：AI 能够写出惊人连贯的文章，回答复杂问题，甚至生成代码。这确实令人叹为观止。但如果你曾
Link
– Gladstone Institutional Advisory LLC Raises Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)
2025-02-17 08:43:01 | ETF Daily News
Gladstone Institutional Advisory LLC grew its holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT – Free Report) by 75.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm ow…
Link
– Understanding the Language of Life’s Biomolecules Across Evolution at a New Scale with Evo 2
2025-02-19 17:14:54 | Nvidia.com
AI has evolved from an experimental curiosity to a driving force within biological research. The convergence of deep learning algorithms, massive omics datasets, and automated laboratory workflows has…
Link
Analysis of Today’s Rally
**Checkpoint Therapeutics (CKPT) Stock Rally: Merger Announcement Drives Gains**
Checkpoint Therapeutics (CKPT) experienced a significant stock rally today. This surge is primarily attributable to the recently announced merger agreement. The company will be acquired by a subsidiary of Sun Pharmaceutical Industries. This news is based on the SEC filings released today.
The merger agreement, detailed in multiple 8-K filings, clearly explains today’s movement. Sun Pharma will acquire CKPT in a deal valued at up to $416 million. Stockholders will receive $4.10 in cash per share. A contingent value right (CVR) adds potential upside. This CVR could deliver an additional $0.70 per share.
The acquisition news swiftly boosted investor confidence in CKPT. The offer price provides a premium over recent trading levels. This perceived value immediately attracts buyers to the stock. The CVR provides further incentive, with potential gains tied to future milestones. The market responded favorably to this news.
While Gladstone Institutional Advisory LLC increased its CKPT holdings recently, this is not the primary driver of today’s surge. The Fortress Biotech Form 4 filing is also not impactful. CEO James Oliviero’s earlier stock disposition is rendered irrelevant. The merger agreement overshadows all other recent news.
In conclusion, the definitive merger agreement with Sun Pharma is the key catalyst. The attractive cash offer and potential CVR are driving the rally. Investors are betting on the deal’s successful completion. CKPT’s future as a Sun Pharma subsidiary appears bright.
This stock has shown a change of 67.21% today.
Please consider that all investment decisions carry risk;
none of the content here should be construed as financial advice.
Always do your own research or consult a professional before making investment decisions.
The information provided in this article is for informational purposes only
and does not constitute legal, tax, or investment advice.
Investing involves risk, including the potential loss of principal.
Leave a Reply